PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent

Katherine A Fantauzzo1, Philippe Soriano

  • 1Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.

Insights

Platelet-derived growth factor receptor alpha (PDGFRα) signaling, mediated by phosphatidylinositol 3-kinase (PI3K), is crucial for skeletal development. This study identifies p53 as a novel downstream effector regulating cell survival and proliferation during this process.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Genetics

Background:

  • Phosphatidylinositol 3-kinase (PI3K) is a key downstream effector of Platelet-Derived Growth Factor Receptor alpha (PDGFRα) signaling in murine skeletal development.
  • Mutant mice lacking PI3K binding to PDGFRα exhibit significant skeletal defects, including issues with palatal shelves, shoulder girdle, vertebrae, and sternum.

Purpose of the Study:

  • To identify proteins phosphorylated by Akt downstream of PI3K-mediated PDGFRα signaling.
  • To elucidate the role of these identified proteins in skeletal development, focusing on cell survival and proliferation.

Main Methods:

  • Immunoprecipitation of Akt phosphorylation substrates from PDGF-AA-treated primary mouse embryonic palatal mesenchyme (MEPM) lysates.
  • Analysis of immunoprecipitated peptides using nanoliquid chromatography coupled to tandem mass spectrometry (nano-LC-MS/MS).
  • Assessment of MEPM cell survival with PI3K inhibitors and proliferation in response to PDGF-AA in mutant cells; investigation of Ybox1-p53 interaction and Trp53 expression; analysis of vertebral defects in Trp53-null mutant mice.

Main Results:

  • A list of 56 proteins, including 10 involved in cell survival and proliferation, was identified as Akt phosphorylation substrates.
  • MEPM cell survival was impaired by PI3K inhibition, and mutant cells showed no proliferation in response to PDGF-AA.
  • Ybox1 was identified as a regulator of cell survival via p53, binding the Trp53 promoter and p53 protein, with decreased Trp53 expression observed upon PDGF-AA treatment.
  • Introduction of a Trp53-null allele mitigated vertebral defects in the PDGFRα mutant mice.

Conclusions:

  • p53 is identified as a novel effector downstream of PI3K-engaged PDGFRα signaling.
  • This pathway regulates cell survival and proliferation essential for skeletal development in vivo.
  • Targeting this pathway could offer therapeutic strategies for skeletal development disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K